Procter & Gamble Heads For The Medicine CabinetZachary Schiller
John E. Pepper, Procter & Gamble Co.'s new CEO, was quick to signal his priorities after taking the top job on July 1. Opening a $280 million health-research center outside Cincinnati on July 19, Pepper put drugs--both over-the-counter and prescription--near the top of his agenda. His lofty aim: to double P&G's $3 billion health business by 2000, and boost it to as much as 20% of sales in the next decade, twice its present share.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.